Objective: Retrospective studies have shown home oxygen to be a safe alternative to hospitalization for some patients with bronchiolitis living at high altitudes. We aimed to prospectively describe adverse events, follow-up, duration of home oxygen, factors associated with failure, and caregiver preferences.
H ypoxia is a common reason for hospitalization for patients with bronchiolitis. Pulse-oximetry often influences the decision to admit 1, 2 and can lead to prolonged hospitalization for supplemental oxygen, [3] [4] [5] often after work of breathing has resolved. 5, 6 We have seen a recent decrease [7] [8] [9] [10] in the previously rising hospitalization rate for bronchiolitis in the United States, which had increased 152% for infants less than 1 year of age from 1980 to 1996 to 31.2 per 1,000 (National Hospital Discharge Survey). 11 As of 2009, bronchiolitis admission rates are down to 19.2 per 1,000 (Healthcare Cost and Utilization Kid's Inpatient Database) 11 but costs associated with bronchiolitis hospitalizations among non-high-risk infants and children are rising ($5,432 in charges in 1997 to $10,289 in 2012) despite little change in associated morbidity and mortality and a decrease in median length of stay (LOS; 2.28 days in 1997 to 1.96 days in 2012). 10 Concerns over hospital overcrowding and healthcare costs have led to consideration of outpatient oxygen therapy as a possible alternative to hospitalization for infants and children with bronchiolitis. 12, 13 Studies focusing on the discharge of bronchiolitis patients on oxygen have shown decreased hospital LOS.
14 Emergency department (ED) discharge on oxygen has also been associated with high caregiver and primary care physician (PCP) satisfaction and safety. 15, 16 Retrospective studies of ED-initiated home oxygen for bronchiolitis have demonstrated a 6% to 9% readmission rate 16, 17 without any adverse outcomes (defined as positive pressure ventilation [PPV] including endotrachial intubation and ventilation, continuous positive airway pressure [CPAP] or bilevel positive airway pressure [BiPAP] , or critical care admission). 16 This suggests that home oxygen is a safe and effective alternative to hospitalization for uncomplicated (otherwise well-appearing, well-hydrated infants and children in no to mild respiratory distress) hypoxic patients with bronchiolitis who have previously been hospitalized for supplemental oxygen. However, beyond the initial randomized controlled trial that studied only 37 patients who were discharged home on oxygen, 15 no other prospective data exist on outpatient follow-up, adverse events, duration of home oxygen, or caregiver preferences. We aimed to investigate these important outcomes of home oxygen for bronchiolitis.
METHODS

Study Design and Setting
This was a prospective, observational study of previously healthy infants and children with acute bronchiolitis and hypoxia, who were discharged home from an academic ED at a free-standing pediatric hospital on oxygen during three consecutive bronchiolitis seasons (December-April) from 2011 to 2014. Data were collected at the initial ED visit and via a series of telephone interviews after subjects were discharged home on oxygen.
This study was approved by the Colorado Multiple Institutional Review Board. Documentation of consent was waived to capture all subjects discharged home on oxygen. Guardians were instead given information about the study and were given the option to "opt out" of follow-up telephone calls. Caregivers were then asked to confirm verbal consent at each follow-up telephone interaction.
Study Population
All ED patients with diagnoses of bronchiolitis and hypoxia (defined as pulse oximetry oxygen saturation [SpO 2 ] < 90% in an awake infant or < 88% in a sleeping infant) who were started on the home oxygen pathway, per the clinical care guideline (CCG) for bronchiolitis at our pediatric tertiary care center, were approached for the study (Figure 1 ). If these criteria are met, the patient can be discharged home from the ED with a portable oxygen tank with home delivery of prolonged-use oxygen prearranged and follow-up planned within 24 hours. Home pulse oximetry is not part of our home oxygen protocol. Since we aimed to study the use of home oxygen for bronchiolitis via this protocol, and clinical decision making and disposition were ultimately left up to the provider, we enrolled all otherwise healthy, nonpremature (≥37 weeks gestational age at birth) subjects with clinical bronchiolitis between the ages of 3 and 18 months, with plan for discharge home on oxygen, regardless of whether or not other parameters (such as "first" episode of wheezing) met the hospital CCG criteria.
Study Protocol and Measurements
During the observation period, study information was provided and explained to the caregiver. Since participation in this study did not alter treatment, LOS, or follow-up, written consent was not obtained. Verbal consent was obtained for collection of baseline data and with each telephone encounter. A waiver of consent was granted for subjects who were admitted or lost to follow-up (LTF). The study was limited to English and Spanish speakers. Demographics, smoke exposure information, visit date, duration of illness, lowest room air (RA) SpO 2 , any ED testing or treatment, and oxygen flow rate were recorded at the initial visit.
After discharge on home oxygen, follow-up telephone interviews were conducted by trained research assistants on postdischarge days 3 (range = 2-4), 7 (range = 6-8), 14 (range = 13-15), day 21 (range = 20-22), and day 28 (range = 27-29) as needed until home oxygen was stopped. Caregivers were asked about follow-up, changes in oxygen flow, increased work of breathing, ED visits, and hospitalizations. Caregivers not reached after three attempts were sent a ACADEMIC EMERGENCY MEDICINE • August 2017, Vol. 24, No. 8 • www.aemj.org survey by both mail and e-mail (if e-mail address was provided) requesting the home oxygen stop date and questions about caregiver preferences and opinions regarding home oxygen. If still on oxygen at 4 weeks, or if LTF, the subject's PCP was contacted by phone and mail regarding alternate diagnoses and oxygen stop date. During the final interview, caregivers were questioned about missed work, daycare attendance, and overall satisfaction and comfort with home oxygen.
For subjects who were discharged on home oxygen but subsequently hospitalized at our institution ("home oxygen failures"), the electronic health record was reviewed retrospectively. Date, place (general pediatrics ward or intensive care unit [ICU] ) and reason for admission, any advanced airway intervention or PPV (endotracheal intubation, CPAP, BiPAP), LOS, additional diagnoses, and discharge information were collected.
Additionally, some subjects enrolled with the intent of discharge on home oxygen had a change in disposition during the observation period and were hospitalized rather than discharged. The same data were collected retrospectively for this "primary admit group." Data Analysis Data were managed using REDCap electronic data capture tools hosted at University of Colorado, Denver. 18 Data were analyzed using SAS 9.3 (SAS Institute). We calculated descriptive statistics, chi-square for categorical variables or Fisher's exact test for small cell sizes (≤5), and Wilcoxon rank sum for nonnormally distributed continuous variables. p-values < 0.05 were considered statistically significant.
RESULTS
Over three consecutive winters, 274 subjects were enrolled. Of these, 48 (17.5%) were hospitalized and 225 (82.1%) were discharged home on oxygen ( Figure 2 ). One subject was discharged on RA and was excluded from further analyses. A total of 196 (87.1%) successfully completed their course at home while 11 (4.9%) subsequently required hospitalization. At least partial data, including oxygen discontinuation information, were available on all but 18 (11%) subjects who were LTF. Clinical data were available for 37 subjects who did not complete the satisfaction survey.
Three groups of subjects were analyzed: subjects who began the home oxygen pathway but did not complete it and were admitted to the hospital (primary admits group, n = 48); those discharged on oxygen who were successfully treated as outpatients (home oxygen success group, n = 196); and those who were discharged on oxygen but required secondary hospitalization (home oxygen failure group, n = 11). There were no statistically significant differences in age, sex, presence or absence of PCP, or smoke exposure between these groups (Table 1) . Several statistically significant differences were noted, however. More home oxygen subjects had public or no insurance than admitted subjects (p = 0.0127). Admitted patients were, more likely to receive nebulized albuterol (8 [17%] vs. 10 [4%], p = 0.0029) or racemic epinephrine (13 [27%] vs. 4 [2%], p < 0.0001) than home oxygen patients. ED testing was uncommon in either group and differences were subtle. Chest radiograph was the most common diagnostic test performed in 12% (28) of the home oxygen group and 19% (9) of the admitted group (p = 1).
Primary Admits Group
For the subjects in the primary admits group, there were often multiple reasons for admission with the most common being: increased work of breathing (56%), increased oxygen requirement (40%), and need for frequent suctioning (27%; Table 2 ). Most were admitted to the general pediatrics ward and required only supplemental oxygen; three subjects received heated high-flow nasal cannula (HHFNC). The median LOS was 2 days. Fifty-six percent (27/48) were discharged from the inpatient unit on home oxygen.
Discharged From the ED on Home Oxygen
Of the 225 subjects discharged from the ED on home oxygen, 145 (64%) had lowest RA SpO 2 of 85% to 89%, 69 (31%) 80% to 84%, and eight subjects (3%) had a RA SpO 2 < 80%. Most (81%) subjects were discharged on 0.5 liters per minute (LPM) of oxygen, 17% (39) were discharged on 0.25 LPM, and four were discharged on 0.375 LPM or less. PCP follow-up occurred at a median of 3 (interquartile range [IQR] = 2-4) days and 67% (151/225) had a follow-up visit prior to the first phone interview. A total of 196 (87%) subjects were successfully treated as outpatients and 11 (5%) required admission (Table 1 ). There were no statistically significant demographic differences between the home oxygen success and home oxygen failure groups.
Home Oxygen Success Group
Of the home oxygen subjects who were successfully treated as outpatients, 84% (188/196) completed the final satisfaction survey. The median duration of home oxygen was 7 days (IQR = 5-10 days). The median number of caregiver missed work-days was 1 day (IQR = 0-3). The median caregiver comfort level with home oxygen was 9 (IQR = 8-10) on a scale of 1 to 10 with 1 being "very uncomfortable" and 10 being Home Oxygen Failure Group (Secondary Admits) Eleven (4.9%) subjects discharged home on oxygen were subsequently admitted to the hospital (Table 3) . One subject was admitted to an outside institution. In this case, data were limited to parental report. All outpatient failures had increased work of breathing, and half reported feeding difficulties. Three subjects were admitted to a critical care unit (two to the pediatric ICU [PICU] and one to the neonatal ICU [NICU]); however, this subject was admitted to the NICU due to age and did not require critical care interventions. Four subjects were treated with HHFNC. One subject required positive pressure support upon admission. This was a 7-month-old who had had one PCP followup visit on home oxygen day 1, at which he was wellappearing. On home oxygen day 2, he was referred to the ED by PCP for respiratory distress. CPAP was started in the ED. He was admitted to the PICU, escalated to BiPAP, and later required endotracheal intubation 2 days into his ICU stay.
The median LOS was 5 days (IQR = 3-6 days) for these secondary admits. Seven of 10 subjects were again discharged home on oxygen after their inpatient stay. Despite outpatient treatment failure, caregivers of the home oxygen failure subjects still reported a home oxygen comfort level of 9 (IQR = 7-10).
Home Oxygen Concerns
Twenty percent (45/225) of caregivers reported problems with the home oxygen. There was not any difference between the home oxygen success and failure groups with regard to percentage of caregivers reporting problems. The most frequent concern was child noncompliance, reported by 27 caregivers, which was unrelated to the age of the subject. Three caregivers had difficulty operating the oxygen tank, and three caregivers reported that they ran out of oxygen. Other concerns primarily involved complaints about the home health companies providing the oxygen, delay in the home health company receiving the home oxygen order or discontinuation order, difficulty figuring out the proper flow rate after leaving the hospital, and tangling of the child in the oxygen tubing. One caregiver reported late delivery of the oxygen. While 179 caregivers reported no additional concerns, some noted inconvenience and others had questions about There were no statistically significant differences between these two populations. Data are reported as median (IQR), or number (%), median (25th, 75th percentile). HR = heart rate; IQR = interquartile range; LPM = liters per minute; NA = not applicable; PCP = primary care physician; Tmax = maximum documented temperature. *Primary admits versus home O 2 , p = 0.0127. †"Other language" made up 1% of the home O 2 group and 6% of the admitted group. ‡Primary admits versus home O 2 , p = 0.0091. viral illnesses and the expected duration of home oxygen.
Caregiver Satisfaction With Home Oxygen
The final survey was completed by 188 caregivers. Comfort with home oxygen was similar for both the success and the failure groups with a median of 9 of 10. With regard to the 8-hour observation period, 145 (64%) felt that it was appropriate, 35 (16%) felt that it was too long, and only eight (4%) felt that it was too short. Caregivers of subjects in the home oxygen failure group were more likely to feel that the observation period was too short (33% (3) vs. 3% (5)) in the success group (p = 0.0039)). Eighty-eight percent (166/ 188) reported that they would again choose home oxygen over hospitalization. For the 12% (22/188) who preferred hospitalization, reasons included child noncompliance, difficulty arranging time off of work to care for the child, difficulty traveling to PCP appointments, communication challenges between PCP and the oxygen company, and most commonly, feeling scared or uncomfortable (n = 8) and concern about the lack of monitoring (n = 9) at home.
Subjects Lost to Follow-up
The 18 subjects who were LTF were also analyzed. In four cases, caregivers refused participation at the first phone interview. For nine subjects, neither their caregivers nor their PCP could be reached or PCP had no record of oxygen discontinuation. One subject remained on oxygen beyond 29 days and the listed PCP had no record of the subject. The remaining six subjects were LTF midway through the study and the listed PCP was either incorrect or had limited knowledge of the subject. Lost to follow-up subjects were demographically similar to both the home oxygen success and the home Data are reported as number (%) or median (25th, 75th percentile). BiPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; HHFNC = heated high-flow nasal cannula; LOS = length of stay; LPM = liters per minute; NICU = neonatal intensive care unit; PICU = pediatric intensive care unit. *Other reasons for admission included pneumonia (n = 2), persistent tachycardia (n = 2), new concerns regarding home smoke exposure (n = 1), and one subject for whom the reason for admission was unclear. Data are reported as number (%) or median (25th, 75th percentile). BiPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; HHFNC = heated high-flow nasal cannula; LOS = length of stay; NICU = neonatal intensive care unit; PICU = pediatric intensive care unit. *Inpatient data are incomplete for one subject who was admitted to an outside hospital. Data for this subject were obtained from caregiver report. †One subject was admitted to the NICU due to age rather than critically ill status.
ACADEMIC EMERGENCY MEDICINE • August 2017, Vol. 24, No. 8 • www.aemj.org oxygen failure groups with regards to sex, race, language, and PCP status. There were statistically significant differences between the success and LTF groups in insurance status (74% of the success group had public or no insurance vs. 95% in the LTF group [p = 0.048]) and smoke exposure (reported in 15% of the success group and 45% of the LTF group [p = 0.008]). Duration of symptoms on presentation, lowest ED SpO 2 , ED workup and treatment, and oxygen flow rates were similar across all groups. Days to follow-up and home oxygen issues were also similar across all groups, although data are limited in the LTF group. No subjects in the LTF group were admitted to our institution.
DISCUSSION
This is the first known prospective study of home oxygen for bronchiolitis since publication of the initial randomized controlled trial of home oxygen versus admission in 2006. 15 This study again demonstrates that home oxygen can be a safe and effective alternative to hospitalization for some patients with bronchiolitis and hypoxia with low rates of subsequent admission and complications. Home oxygen is well received by caregivers who report high levels of satisfaction and comfort with this process. Daycare attendance data suggest that some daycare providers are also comfortable with home oxygen. We did not identify any factors associated with home oxygen pathway failure (primary admits) or home oxygen treatment failure.
The home oxygen admission and complication (need for PPV) rates of 4.9 and 0.4%, respectively, are similar to those noted in previous retrospective studies that reported 6 16 and 9% 17 admission rates, though no subjects required PPV in these studies. Our 4.9% readmission rate is also similar to the 4% return plus admission rate reported by Halstead et al. 16 for patients with bronchiolitis who were initially discharged from the ED on RA, suggesting that the risk of deterioration associated with home oxygen is similar to that of patients with mild bronchiolitis treated at home without medical intervention.
The 8-hour observation period, included in our home oxygen guideline to allow for varying stages of illness at the time of presentation, identified a significant population (17.5%) who would be better cared for as inpatients, either due to deterioration in respiratory status (79% [37/48]) or because either the caregiver or the provider was uncomfortable with discharge on oxygen (18% [8/48] ). The observation time is a key element in our home oxygen process from both a clinical and a caregiver comfort and standpoint.
Neither the age of the patient, the day of illness, or fever proved to be associated with failure during either the observation period or during outpatient home oxygen. Although not statistically significant, we found tachycardia to be a potential red flag for failure of outpatient care. This is not specific to bronchiolitis, however, as abnormal vital signs are known to be associated with an increased risk of serious illness and should prompt providers to rule out other diagnoses.
In our study population, more home oxygen subjects had public or no insurance than admitted subjects. This was an unexpected finding and contrasts findings by Sandweiss et al., 19 who reported that some providers found it difficult to arrange home oxygen equipment for their Medicaid patients. It is unlikely to be related to income/profitability bias, as ED providers at our public, tertiary care center have no financial relationship or benefit from admission of insured patients or discharge of those who are not. We hypothesize that some of this may caregiver driven, with caregivers with no insurance advocating for hospital discharge. Regardless, this does speak to provider comfort with home oxygen and outpatient care, in what has previously been viewed as a potentially vulnerable population with little access to healthcare resources. Indeed, insurance status was not a factor in home oxygen failure.
Both our bronchiolitis home oxygen CCG and discharge instructions advise outpatient follow-up within 24 hours. Potential subjects who do not have a PCP are therefore not eligible for home oxygen. In instances when 24-hour PCP follow-up is clearly not possible (on holidays or weekends, for example), patients who are discharged home on oxygen are asked to return to the ED for a brief screening examination and pulse oximetry check in lieu of a PCP visit. Despite this, the median time to follow-up among the study population was 3 days. In contrast to our findings, in a survey of Colorado and Utah PCPs who have managed patients with bronchiolitis on home oxygen, 85% of PCPs reported that they generally see patients within 1-2 days of ED discharge. 20 Similarly, Flett et al. 17 found that outpatient follow-up occurred > 24 hours later in only 17.5% of patients discharged home on oxygen. It is unclear whether delay in follow-up among our subjects was due to caregiver failure to schedule an appointment, low appointment availability due to high clinic volumes, or recommendation of PCPs. Previous studies have shown that there are a variety of oxygen weaning methods employed by PCPs, including telephone follow-up and incremental weaning of oxygen at home, which may be dictating the timing of follow-up visits. 20 It is reassuring, however, that delay in follow-up was not associated with return ED visits or adverse outcomes. This suggests that 24-hour follow-up may not be necessary for some patients on home oxygen but further studies will be needed before recommendations are changed.
Home oxygen failures had a longer LOS, were more likely to be admitted to the PICU, and more likely to receive HHFNC than the primary admits. Although it is difficult to draw conclusions from such a small group (n = 11), this suggests that the home oxygen failure population may have been sicker than the primary admits. We also cannot determine the effect of possible differences in oxygen compliance or suctioning that may have occurred between hospitalized and home care subjects and whether this contributed to the subsequent acuity level and disease course of these subjects. Regardless, inpatient providers were no less likely to discharge the secondary admits on oxygen a second time, speaking to the comfort of both the providers and the caregivers with home oxygen.
Given the lack of other effective therapies, supplemental oxygen remains the main therapeutic approach in otherwise uncomplicated patients with bronchiolitis and hypoxia. 21 With hospital overcrowding and changes in healthcare reimbursement, reducing hospitalizations and healthcare costs is paramount. The bronchiolitis home oxygen protocol resulted in an absolute admission rate reduction of 9% at our institution over the course of four seasons (2006-2009) from 40% to 31%. 16 Institutional data from the past 3 years (2013-2015) showed a median LOS of 3.1 days for uncomplicated bronchiolitis admissions (although in our study, it was 2 days). The mean payer charge for this same period was over $2,700/day. While the mean cost associated with outpatient follow-up and home oxygen supplies is difficult to determine due to differences in home health provider charges, contracts, and insurance reimbursements, discharge on home oxygen likely carries significant cost savings over hospital admission despite a potentially longer duration of supplemental oxygen in some patients (mean = 7 days).
While few problems with home oxygen were reported in our study, child noncompliance was reported in 14% (27/188) of cases. Because subjects in this study were not continuously monitored with pulse oximetry, we were unable to determine the degree or duration of transient hypoxia that may have occurred as a result. However, reported noncompliance was not associated with hospitalization. Similarly, Principi et al. 22 recently reported that even well-appearing infants with bronchiolitis who were normoxic on initial evaluation had SpO 2 desaturations while at home, but these were not associated with return visits. The authors suggest that infants with bronchiolitis who are deemed suitable for discharge from a respiratory and hydration standpoint should not undergo further SpO 2 measurements and that spot checking is less likely to detect clinically unimportant desaturations than continuous monitoring. This supports our model of pulse oximetry spot checks during PCP follow-up rather than continuous monitoring.
There is currently no evidence that transient mild oxygen desaturations during acute bronchiolitis are associated with adverse outcomes. Further studies on the long-term effects of transient acute illness-associated hypoxia in the otherwise well-appearing child are warranted. Until these data exist and thresholds for acceptable transient hypoxia can be determined, supplemental oxygen will remain a mainstay of treatment for bronchiolitis-associated hypoxia and home oxygen will be an effective alternative to hospitalization for some of these patients.
LIMITATIONS
This study has several limitations. While we have at least partial data, including duration of home oxygen on 207 of 225 (92%) of subjects, data are incomplete on some subjects. It is possible that subjects LTF may have had an unreported adverse event or admission to another institution and outside hospital data were not available. Interviews were dependent on caregiver report and may be prone to bias. Additionally, because admitted patients were studied retrospectively, some nuances of medical decision making may have been missed. Unfortunately, due to hospital overcrowding and ED boarding of patients, we were unable to determine at what time during the observation period changes in disposition were made. Each individual provider's comfort with degree and duration of hypoxia may differ and, thus, may affect which patients are started on the home oxygen pathway, admitted, or discharged on RA. Finally, this was a single-center study performed at an altitude of roughly 5,200 feet (1,609 meters), which may affect generalizability. However, with recent evidence-based guidelines that recommend supplemental oxygen as the only effective therapy, and suggest limited utility for continuous pulse oximetry, there may be little to be gained from hospitalization of patients with mild to moderate bronchiolitis. While further studies of home oxygen at sea-level locales are warranted prior to widespread implementation, our data add to the growing body of evidence that suggests that outpatient oxygen therapy is safe and effective for some patients. While there may be fewer comparable mild to moderately ill hypoxic patients at lower altitudes, ED-initiated outpatient oxygen therapy deserves investigation as a means of reducing bronchiolitis hospitalizations, costs, and hospital overcrowding, in addition to increases in patient satisfaction, on a large-scale, national level.
CONCLUSIONS
Our results confirm that home oxygen is an effective and sustainable alternative to hospital admissions for uncomplicated, hypoxic bronchiolitis and is well received by caregivers. The low incidence of adverse events adds to the evidence that home oxygen is safe for some patients with bronchiolitis. Patients should be observed on oxygen prior to discharge to identify individuals at risk of deterioration. Attention should be paid to work of breathing and hydration status. Next steps should include exploration of outpatient oxygen therapy in other locations, altitudes, and environments.
